Review Article
Sphingolipids in High Fat Diet and Obesity-Related Diseases
Table 2
Sphingomyelin regulation by HFD or fatty acids.
| Tissue | Experimental model | Sphingomyelin species | Alteration | Reference |
| Liver | 60% HFD for 5 weeks in Wistar rats | NS | Increased | [40] | 34% HFD for 3 weeks in Wistar rats | SM16:0, SM18:0, and SM18:1 | Increased (nuclei) |
[29] | SM16:0, SM18:0 | Increased (total) | 58% HFD for 16 weeks in C57BL/6 mice | NS | Increased | [54] |
| Skeletal muscle | 60% HFD for 6 weeks in C57BL/6 mice | SM18:1 | Increased |
[41] | SM18:0, total SM | Decreased |
| Adipose tissue | 42% HFD for 16 weeks in C57BL/6 mice | SM14:0, SM16:0, SM16:1 SM18:0, and SM18:1 | Increased | [11] |
| Plasma/serum | 45% HFD for 14 weeks in C57BL/6 mice | SM16:0, SM18:0, SM16:1, SM18:1, and SM22:1 | Increased | [33] | 58% HFD for 16 weeks in C57BL/6 mice | NS | Increased | [54] |
|
Heart | 60% HFD for 16 weeks in C57BL/6 mice | SM 16:0, SM18:0, and SM18:1 | Increased | [15] | 41% palmitate-enriched HFD for 12 weeks in C57BL/6 | SM16:0, SM20:0, SM24:0, and SM24:1 | Increased | [98] |
|
|
NS = not specified.
|